Evidence map›Paper›PMID 35293672›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2022

Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation.

Harald Hampel, Andrea Vergallo, Takeshi Iwatsubo, Min Cho, Kiyoshi Kurokawa, Huali Wang, H Ricky Kurzman, Christopher Chen

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. A multilevel conceptual framework for dementia: from life-course mechanisms to public health strategies.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Ibrain · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Harald HampelNeurology Business Group, Eisai Inc., Nutley, New Jersey, USA.ORCID 0000-0003-0894-8982
Andrea VergalloNeurology Business Group, Eisai Inc., Nutley, New Jersey, USA.
Takeshi IwatsuboUniversity of Tokyo, Tokyo, Japan.
Min ChoNeurology Business Group, Eisai Inc., Nutley, New Jersey, USA.
Kiyoshi KurokawaNational Graduate Institute for Policy Studies, Chairman, Health and Global Policy Institute, Tokyo, Japan.
Huali WangPeking University Institute of Mental Health (Sixth Hospital), Beijing, China.
H Ricky KurzmanNeurology Business Group, Eisai Inc., Nutley, New Jersey, USA.
Christopher ChenDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Eisai (United States) · USNational Graduate Institute for Policy Studies · JPNational University of Singapore · SGPeking University · CNThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With population growth and aging, the number of people with dementia and related disorders will grow substantially in the years ahead, bringing with it significant societal, health-care, and economic challenges. Here, we analyze dementia policies of seven major countries in Asia/Pacific, Europe, and North America to identify opportunities for early actions to mitigate disease burden. We find that most countries are addressing this need by including a specific focus on early action in their national dementia strategies (five of seven countries), implementing public health initiatives for risk reduction, prevention, and early detection and diagnosis (six of seven countries); supporting enabling research for early detection and risk reduction (six of seven countries); and enacting a system for early, regular brain health screening (one of seven). We discuss risks and opportunities for integrating early action policies and conducting additional systematic research to understand the potential benefits and impacts of these policies.

Indexed as

Delivery of Health CareDementiaCost of IllnessHumansPolicyPublic Health

Identifiers

PMID35293672
PMCPMC9790361
OpenAlexW4220903895

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.